Background: The hydrophilic bile salt ursodeoxycholate (UDCA) inhibits injury by hydrophobic bile acids and is used to treat cholestatic liver diseases. Interestingly, hepatocyte cell death from bile acid-induced toxicity occurs more frequently from apoptosis than from necrosis. However, both processes appear to involve the mitochondrial membrane permeability transition (MPT). In this study, we determined the inhibitory effect of UDCA on deoxycholic acid (DCA)-induced MPT in isolated mitochondria by measuring changes in transmembrane potential (APm) and production of reactive oxygen species (ROS). In addition, we examined the expression of apoptosis-associated proteins in mitochondria isolated from livers of bile acid-fed animals. Materials and Methods: Adult male rats were maintained on standard diet supplemented with DCA and/or UDCA for 10 days. Mitochondria were isolated from livers by sucrose/percoll gradient centrifugation and MPT was measured using spectrophotometric and
Introduction
It is widely recognized that accumulation of hydrophobic bile acids plays a major role in liver injury during cholestasis (1) (2) (3) . In contrast, hydrophilic bile acids such as ursodeoxycholic acid (UDCA) appear to protect against such injury (4) (5) (6) . We have recently demonstrated that toxic bile acids directly induce apoptosis in liver tissue in situ (7) . UDCA prevented deoxycholic acid (DCA) toxicity by a mechanism beyond the simple displacement of hydrophobic bile acids and including a direct effect at inhibiting apoptosis in liver tissue. In addition, UDCA was shown to significantly modulate the apoptotic threshold in hepatic and nonhepatic cells from a variety of non-bile acid-inducing agents by preventing mitochondrial membrane perturbation. These observations supported a unique role for UDCA in regulating apoptosis through a mechanism involving mitochondrial function.
Several independent studies have shown that bile acid cytotoxicity may be a consequence of mitochondrial dysfunction. In vitro, bile salts cause impaired state III respiration when added to mitochondria or permeabilized hepatocytes (8, 9) , and ATP depletion occurs during hepatocyte necrosis (8) . In vivo, swollen mitochondria are observed in bile duct-ligated rats and in humans with cholestasis (10) , and mitochondria isolated from bile duct-ligated rats also have impaired state III respiration (1 1). Moreover, mitochondrial dysfunction during hepatocyte necrosis appears to be a consequence of an increase in mitochondrial membrane permeability transition (MPT) (12, 13) . The MPT may occur by two mechanisms involving nonspecific injury to the membrane lipids or opening of a multiprotein pore complex in the inner mitochondrial membrane. As a consequence of MPT, the mitochondrial transmembrane potential (Aim) collapses, thereby uncoupling the respiratory chain and inhibiting ATP biosynthesis. This results in production of reactive oxygen species (ROS), including superoxide anion and peroxides, and subsequent release of inner mitochondrial membrane proteins (14, 15) . Opening of the permeability transition pore may be influenced by multiple parameters, many of which are associated with apoptosis. These include ROS production, primary activation of ICE-like caspases, modification of the Bcl-2 complex, and sustained increases in cytosolic calcium levels, resulting in a self-amplifying cascade (15) . Additionally, a reduction of ATm and production of ROS were recently shown to play a major role during Baxinduced cell death (16) .
A common event in apoptosis, regardless of the inducing signal and cell type, appears to be the disruption of mitochondrial function. It may, in fact, mark an almost irreversible commitment to cell death by apoptosis (15) . Since previous work had suggested that UDCA inhibited mitochondrial membrane damage from other hydrophobic bile salts (17) , we isolated mitochondria from rat livers to determine whether DCA induces the MPT associated with mitochondrial membrane dysfunction in apoptosis. Then, to establish whether the role of UDCA in modulating DCA-induced apoptosis was related to its ability to inhibit MPT, we measured ATm and ROS production in isolated mitochondria. Finally, apart from two recent reports showing de novo expression of the anti-apoptotic protein Bcl-2 in hepatocytes from bile duct-ligated rats (18) and patients with primary biliary cirrhosis (19) , little is known about the effect of bile acids on apoptosis-related proteins. We therefore characterized apoptosis-related hepatic gene expression in bile acid-fed animals.
The results indicated that UDCA significantly reduced ATm disruption and ROS production associated with DCA in isolated mitochondria, suggesting a possible explanation for its role in preventing MPT. Moreover, the mitochondrial perturbation by DCA was associated with significant modulation of apoptosis-related protein abundance in mitochondrial membranes, possibly altering their channel-forming activity. The study demonstrates that at least one direct mechanism by which UDCA significantly inhibits DCA-induced apoptosis is by preventing MPT. (17, 20) . In short, ani-mals were sacrificed by exsanguination under ether anesthesia and the livers removed and rinsed in normal saline. Approximately 10 g of minced liver was homogenized in an ice-cold solution of 70 mM sucrose, 220 mM mannitol, 1 mM ethylene glycol bis(f3-aminoethylether) -N, N, N', N'-tetraacetic acid (EGTA) and 10 mM HEPES, pH 7.4, as a 10% (wt/vol) homogenate. After 2 low-speed centrifugations, a crude mitochondrial pellet was purified by sucrose-percoll gradient centrifugation (21) . The pellet was resuspended in 2 ml of homogenate buffer, and 1 ml of the resuspended pellet was carefully layered onto a 35-ml self-generating gradient containing 0.25 M sucrose, 1 (22) , lysosomal N-acetyl-,3-glucosaminidase (23) , and microsomal esterase (24) enzymes as described previously. Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad Laboratories) as recommended by the manufacturer. Mitochondrial preparations were also examined for purity by phase-contrast microscopy.
Materials and Methods

Animals and Diets
Spectrophotometric and Fluorimetric Assays of MPT The MPT was assessed using a spectrophotometric assay measuring high-amplitude rapid changes in mitochondrial volume, and a fluorimetric assay quantitating the release of calcein from calcein-loaded mitochondria. The MPT was measured spectrophotometrically as previously described (13, 17) . Briefly, mitochondria (3 mg protein) were incubated in 3 ml of chelex-100-treated respiration buffer (0.1 M NaCl, 10 (17) .
The fluorimetric assay was performed after loading the mitochondria with 10 ,uM calceinacetoxymethyl ester (AM) (Molecular Probes Inc., Eugene, OR) for 30 min at 370C in chelex-100-treated resuspension buffer before purification by sucrose-percoll gradient centrifugation (17) . The assays were performed using calceinloaded isolated mitochondria (1 mg protein/ml) in chelex-100-treated respiration buffer at 370C. For the coincubation assays, the samples were preincubated for 10 bRelative enrichment represents the specific activity for the respective enzyme in the pellet relative to the specific activity in the homogenate.
Western Blot Analysis Cytoplasmic proteins were isolated from rat liver tissue as described previously (28) . Briefly, frozen liver tissue from bile acid-fed rats was ground to a powder in liquid nitrogen using a mortar and pestle followed by Dounce homogenization in hypotonic buffer containing 10 mM Tris, pH 7.6, 5 mM MgCl2, 1.5 mM KAc, and 2 mM dithiothreitol (DTT), supplemented with the CompleteTM protease inhibitor cocktail (Boehringer Mannheim Biochemicals, Inc., Indianapolis, IN) at 4°C. Total liver lysate obtained by Dounce homogenization was centrifuged at 40C for 10 min at 500 x g and the resulting supernatant was centrifuged a second time. Mitochondria were isolated from frozen liver tissue as described above using buffers supplemented with the protease inhibitor cocktail. Cytoplasmic and mitochondrial protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad Laboratories). Proteins were separated using 15% (30:0.2) SDS-PAGE and electrophoretically transferred to nitrocellulose membrane. The membranes were processed for protein detection using the ECLTM system from Amersham Life Science, Inc. (Arlington Heights, IL) as described previously (28 
Results
UDCA Inhibits DCA-Induced MPT Phase-contrast microscopy of the isolated mitochondria indicated that they were intact, free of contamination and exhibited minimal clumping. In addition, the purity of the isolated mitochondrial fraction was assessed by marker enzyme studies. As shown in Table 1 , the purified mitochondrial pellet was highly enriched in mitochondrial malate dehydrogenase activity with minimal contamination by lysosomal N-acetylf3-glucosaminidase or microsomal esterase activity. Having established the authenticity of the mitochondrial fraction, the MPT was measured using spectrophotometric and fluorimetric methods (Fig. IA, B) . It has been previously reported that incubation with glycochenodeoxycholic acid resulted in hepatocyte toxicity (8) and induced MPT in isolated rat liver mitochondria (17, 30) . In this study, incubation with DCA also induced significant changes in the MPT of isolated hepatic mitochondria (Fig. 1A) . Mitochondrial swelling inicreased 25-fold over control values after a 5-min incubation with DCA (p < 0.001). In contrast, incubation with UDCA alone produced no significant changes in permeability relative to control values. Moreover, coincubation with UDCA protected against DCA-induced mitochondrial swelling by >40%o (p < 0.001). Membrane permeability was also assessed using calcein-loaded mitochondria. In fact, incubation with DCA resulted in significant unquenching of calcein fluorescence, indicative of increased mitochondrial leakage (Fig. iB) . Coincubation with UDCA inhibited DCA-induced calcein release from mitochondria by almost 50%0 (p < 0.001), which is in agreement with the observed inhibition of mitochondrial swelling.
The dose-response effect of DCA on MPT was examined and is shown in Figure 2A . Incubation with DCA resulted in high-amplitude mitochondrial swelling that was rapid and dose dependent. The 4-fold over controls after incubation with 50 ,uM to greater than 25-fold after incubation with 200 ,uM DCA (p < 0.001). Significant inhibition of the DCA-induced MPT by 500 ,uM UDCA occurred in both the 100 (p < 0.05) and 200 /M DCA (p < 0.001) treatment groups. Additionally, UDCA inhibited the DCA-induced MPT in a concentration-dependent fashion (Fig. 2B1) . When mitochondria suspended in respiration buffer were preincubated with increasing concentrations of UDCA for 5 min prior to the addition of 200 ,uM DCA, swelling decreased from 26.8 + 6.30% with 100 ,uM UDCA to 16.9 + 2.30% with 500 ,uM UDCA (p < 0.001). The addition of UDCA after incubation with DCA did not result in significant reversal of MPT (data not shown). We then determined whether the inhibition of the DCA-induced MPT by UDCA was bile acid specific or simply a property of hydrophilicity. To address this issue, isolated mitochondria were incubated with a similarly hydrophilic bile acid HDCA. Interestingly, pretreatment of the isolated hepatic mitochondria with 500 ,uM HDCA did not decrease DCA-induced mitochondrial swelling (Fig. 2B) or prevent calcein release.
The significant mitochondrial swelling observed after incubation with DCA suggested that the observed MPT resulted from perturbation of the cyclosporine A/trifluoperazine-sensitive in- ner membrane large conductance channels (megapores), rather than nonspecific membrane disruption (13, 31) . In fact, earlier studies showed that pretreatment of mitochondria with cyclosporine A and/or trifluoperazine inhibited swelling induced by glycine conjugated chenodeoxycholic acid (17 (Fig. 4A) . Similarly, ROS production of superoxide anions and peroxides were reduced 100% and 55%, respectively, (Fig. 4B,  C) when UDCA was coincubated with PhAsO (p < 0.05, or lower). In contrast, coincubation of isolated mitochondria with 500 ,uM HDCA did not prevent DCA-mediated changes in APTm (Fig. 5A ) and ROS production (Fig. 5B, C) . Also, no changes were observed with HDCA alone.
Modulation of Apoptosis-Related Protein Expression with Bile Acid Feeding
To examine the potential chronic effect of bile acids on apoptosis-associated gene expression, we determined liver cytoplasmic and mitochondrial steady-state protein levels for Bcl-2, BCl-XL, Bax, and Bad. Cytoplasmic levels of the proapoptotic protein Bax showed no significant change across all groups of animals regardless of whether bile acids were included in the diet (Fig. 6) We also determined liver cytoplasmic protein levels for c-Myc, p53, and retinoblastoma, as alterations in their expression levels have been associated with hepatocyte apoptosis (32) . Interestingly, bile acid feeding did not induce significant changes in cytoplasmic levels of the tumor suppressor p53 (data not shown). Similarly, no significant changes in cytoplasmic c-Myc or retinoblastoma levels were detected in any of the groups relative to controls.
Discussion
The results of this study demonstrate that DCA induces MPT (7) . This difference, however, may result from anti-apoptotic effects of UDCA, which are independent of mitochondrial function. In this regard, it has been recently shown that the glycine-conjugated form of UDCA inhibits beauvericin-induced activity of caspase 3, a protease involved in cholangiocyte apoptosis (33) . Nevertheless, several cell-free systems have implicated mitochondria and/or mitochondrial proteins as necessary factors for apoptosis (34,3 5) . In fact, MPT is thought to be sufficient to induce both the cytosolic and nuclear events required in the apoptotic cascade (36) . Moreover, it is well established that the apoptotic pathway(s) involving the different proteases and the various mitochondrial constituents are interactive. For example, Bcl-2 expression at the mitochondrial outer membrane inhibits the apoptosis induced by interleukin-1,(-converting enzyme, the mammalian homolog of the C. elegans cell death gene ced-3 (37) . Furthermore, the addition of Bcl-2 to primed Xenopus egg extracts inhibits their ability to induce apoptotic changes in exogenously added nuclei (35) .
In this study, mitochondria were isolated from rat liver to determine whether DCA induces MPT, and whether that perturbation was modulated by UDCA. It now appears that MPT is the earliest mitochondrial membrane event resulting in apoptosis. The results indicated that DCA induces dose-dependent high-amplitude mitochondrial swelling which is significantly inhibited by coincubation with UDCA. The specificity and ability of UDCA to act as a general inhibitor of MPT was determined using another similarly hydrophilic bile acid, HDCA, and the well-characterized MPT-inducing agent, PhAsO (13, 31) . The data indicated that UDCA functions as a general inhibitor of MPT and its effect on MPT was specific and not simply a result of its hydrophilicity. Moreover, the role of UDCA in modulating the apoptotic threshold in vivo and in cultured cells might be mediated in part by its protective effect on megapore function at the mitochondrial membrane.
The ability of UDCA to directly inhibit DCAinduced mitochondrial membrane perturbation was also investigated using the mitochondrial uptake of DiOC6 (3) (42) . DCA feeding simultaneously increased Bcl-2 levels in mitochondria. Interestingly, when UDCA was combined in the diet, it completely inhibited mitochondrial changes in both Bax and Bcl-2 levels associated with DCA feeding alone. These results are interesting in light of the recent report that hepatocytes in bile duct-ligated rats exhibit de novo expression of the anti-apoptotic protein . Immunohistochemical analysis demonstrated that Bcl-2 was more abundant in periportal hepatocytes than pericentral hepatocytes. In contrast, the anti-apoptotic protein BCl-XL was not altered by bile duct ligation, whereas the pro-apoptotic protein Bax increased slightly by Western blot analysis. Our studies using an animal model of bile acid feeding complement the recent report that nuclear DNA fragmentation and Bcl-2 expression was inhibited in patients with primary biliary cirrhosis treated with UDCA (19) .
We also examined the effect of UDCA feeding on the cytoplasmic levels of the apoptosis- .i*i.. related genes. UDCA significantly increased cytoplasmic levels of both BCl-XL and Bad but did not alter Bcl-2 or Bax protein expression. The substantial increase in BCl-XL expression, whose homodimers repress cell death (43) , suggests an additional mechanism by which UDCA might further increase the observed apoptotic threshold. This is particularly interesting since a recent report suggests that BC1-XL apparently regulates both the membrane potential and volume homeostasis of mitochondria (44) . However, it has been controversial whether Bcl-2 and its homolog BC1-XL and Bax influence MPT directly or via an indirect mechanism, such as through the regulation of cytochrome C release (45) (46) (47) . Data from cell-free systems indicate that Bcl-2 can inhibit MPT and the release of apoptogenic proteins from mitochondria (34, 45, 46, 48) . Similarly, BCl-XL prevented cytochrome C release from mitochondria in response to a wide variety of apoptotic stimuli (44) . In contrast, induction of Bax resulted in A/Tm dissipation and ROS production, culminating in cell death even in the presence of a caspase inhibitor, which suggests that activation of caspases result from and do not induce mitochondrial perturbation (16) .
In conclusion, our data support a unique role for UDCA in regulating MPT through a mechanism that may involve an interplay of events at the mitochondrial membrane. Such events appear to include direct prevention of megapore opening and/or inhibition of ATm dissipation and ROS production. In addition, the in vivo studies suggest that bile acids directly or indirectly modulate apoptosis-related protein abundance at the mitochondrial membrane. Finally, the results suggest at least one possible mechanism for the observed beneficial effect of UDCA as a therapeutic agent in the treatment of cholestasis in which increased apoptosis contributes to the pathogenesis of disease.
